glp-1 news today pharma health obesity drugs october 2025 Outlook for obesity in 2025: more Glucagon-like Peptide 1 (GLP-1) Analogues
Description
Koh A, De Vadder F, Kovatcheva-Datchary P, Bckhed F
But the FDA has never approved phentermine for long-term continuous use, and the data supporting extended protocols is thin
Most mild Mounjaro skin rash treatment focuses on relieving itching, reducing inflammation, and monitoring symptoms while the skin heals
both approaches are acceptable
